Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer updated from Revision: v3.3.1 to Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:59:26.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be related to the study, and Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:11:57.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The banner warning about a lapse in government funding and potential delays in updates was removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T06:10:26.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No significant changes were detected; the study details page content, sections, and links appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T00:44:09.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    1%
    Check dated 2025-10-05T05:20:08.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.1%
    Check dated 2025-09-28T02:49:04.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.